BackDesign Therapeutics Overview
Design Therapeutics Inc

Design Therapeutics Discounted Cash Flow

DCF Analysis for DSGN.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.27

Current Fair Value

$0.27
97.6% Downside

Overvalued by 97.6% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading